DOCSLIB.ORG

Psykisk Utviklingshemming Og Forsinket Utvikling

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Psykisk Utviklingshemming Og Forsinket Utvikling Psykisk utviklingshemming og forsinket utvikling Genpanel, versjon v02 Tabellen er sortert på gennavn (HGNC gensymbol) Navn på gen er iht. HGNC >x10 Andel av genet som har blitt lest med tilfredstillende kvalitet flere enn 10 ganger under sekvensering x10 er forventet dekning; faktisk dekning vil variere. Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) AAAS 13666 NM_015665.5 100% Achalasia-addisonianism-alacrimia syndrome OMIM AASS 17366 NM_005763.3 100% Saccharopinuria OMIM Hyperlysinemia OMIM ABCB7 48 NM_004299.4 100% Anemia, sideroblastic, with ataxia OMIM ABCC9 60 NM_005691.3 99% Hypertrichotic osteochondrodysplasia OMIM ABCD1 61 NM_000033.3 97% Adrenoleukodystrophy OMIM ABCD4 68 NM_005050.3 100% Methylmalonic aciduria and homocystinuria, cblJ type OMIM ABHD5 21396 NM_016006.4 96% Chanarin-Dorfman syndrome OMIM ACAD9 21497 NM_014049.4 100% Mitochondrial complex I deficiency due to ACAD9 deficiency OMIM ACADM 89 NM_000016.5 100% Acyl-CoA dehydrogenase, medium chain, deficiency of OMIM ACADS 90 NM_000017.3 100% Acyl-CoA dehydrogenase, short-chain, deficiency of OMIM ACADVL 92 NM_000018.3 100% VLCAD deficiency OMIM ACAT1 93 NM_000019.3 99% Alpha-methylacetoacetic aciduria OMIM ACO2 118 NM_001098.2 100% Infantile cerebellar-retinal degeneration OMIM ACOX1 119 NM_004035.6 100% Peroxisomal acyl-CoA oxidase deficiency OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) ACSL4 3571 NM_004458.2 99% Mental retardation, X-linked 63 OMIM ACTA2 130 NM_001613.2 100% Multisystemic smooth muscle dysfunction syndrome OMIM ACTB 132 NM_001101.3 100% Baraitser-Winter syndrome 1 OMIM ?Dystonia, juvenile-onset OMIM ACTG1 144 NM_001614.3 100% Baraitser-Winter syndrome 2 OMIM ACVR1 171 NM_001105.4 99% Fibrodysplasia ossificans progressiva OMIM ACVR2B 174 NM_001106.3 96% Heterotaxy, visceral, 4, autosomal OMIM ACY1 177 NM_000666.2 100% Aminoacylase 1 deficiency OMIM ADAR 225 NM_001111.4 99% Aicardi-Goutieres syndrome 6 OMIM ADCK3 16812 NM_020247.4 100% Coenzyme Q10 deficiency, primary, 4 OMIM ADK 257 NM_001123.3 100% Hypermethioninemia due to adenosine kinase deficiency OMIM ADNP 15766 NM_015339.3 100% Helsmoortel-van der Aa syndrome OMIM ADRA2B 282 NM_000682.6 100% Epilepsy, myoclonic, familial adult, 2 OMIM ADSL 291 NM_000026.2 100% Adenylosuccinase deficiency OMIM AFF2 3776 NM_002025.3 99% Mental retardation, X-linked, FRAXE type OMIM AFG3L2 315 NM_006796.2 98% Ataxia, spastic, 5, autosomal recessive OMIM AGA 318 NM_000027.3 100% Aspartylglucosaminuria OMIM AGK 21869 NM_018238.3 100% Sengers syndrome OMIM Cataract 38, autosomal recessive OMIM AGL 321 NM_000642.2 99% Glycogen storage disease IIIb OMIM Glycogen storage disease IIIa OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) AGXT 341 NM_000030.2 100% Hyperoxaluria, primary, type 1 OMIM AIFM1 8768 NM_004208.3 100% Cowchock syndrome OMIM Combined oxidative phosphorylation deficiency 6 OMIM AIMP1 10648 NM_004757.3 100% Leukodystrophy, hypomyelinating, 3 OMIM AKT1 391 NM_005163.2 100% Cowden syndrome 6 OMIM AKT3 393 NM_005465.4 100% Megalencephaly-polymicrogyria-polydactyly- hydrocephalus syndrome 2 OMIM ALDH18A1 9722 NM_002860.3 100% Cutis laxa, autosomal recessive, type IIIA OMIM Cutis laxa, autosomal dominant 3 OMIM Spastic paraplegia 9B, autosomal recessive OMIM Spastic paraplegia 9A, autosomal dominant OMIM ALDH3A2 403 NM_000382.2 99% Sjogren-Larsson syndrome OMIM ALDH4A1 406 NM_003748.3 99% Hyperprolinemia, type II OMIM ALDH5A1 408 NM_001080.3 99% Succinic semialdehyde dehydrogenase deficiency OMIM ALDH7A1 877 NM_001182.4 100% Epilepsy, pyridoxine-dependent OMIM ALDOA 414 NM_000034.3 100% Glycogen storage disease XII OMIM ALDOB 417 NM_000035.3 100% Fructose intolerance OMIM ALG1 18294 NM_019109.4 99% Congenital disorder of glycosylation, type Ik OMIM ALG11 32456 NM_001004127.2 100% Congenital disorder of glycosylation, type Ip OMIM ALG12 19358 NM_024105.3 100% Congenital disorder of glycosylation, type Ig OMIM ALG13 30881 NM_001099922.2 99% Congenital disorder of glycosylation, type Is OMIM ALG2 23159 NM_033087.3 100% Myasthenic syndrome, congenital, 14, with tubular aggregates OMIM ?Congenital disorder of glycosylation, type Ii OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) ALG3 23056 NM_005787.5 100% Congenital disorder of glycosylation, type Id OMIM ALG6 23157 NM_013339.3 100% Congenital disorder of glycosylation, type Ic OMIM ALG8 23161 NM_024079.4 100% Congenital disorder of glycosylation, type Ih OMIM ALG9 15672 NM_001077691.1 99% Congenital disorder of glycosylation, type Il OMIM ALMS1 428 NM_015120.4 99% Alstrom syndrome OMIM ALPL 438 NM_000478.4 100% Hypophosphatasia, infantile OMIM Hypophosphatasia, childhood OMIM ALX1 1494 NM_006982.2 100% ?Frontonasal dysplasia 3 OMIM ALX3 449 NM_006492.2 79% Frontonasal dysplasia 1 OMIM ALX4 450 NM_021926.3 99% Parietal foramina 2 OMIM Frontonasal dysplasia 2 OMIM AMER1 26837 NM_152424.3 100% Osteopathia striata with cranial sclerosis OMIM AMT 473 NM_000481.3 100% Glycine encephalopathy OMIM ANKRD11 21316 NM_013275.5 100% KBG syndrome OMIM AP1S2 560 NM_003916.4 100% Mental retardation, X-linked syndromic 5 OMIM AP4B1 572 NM_006594.3 99% Spastic paraplegia 47, autosomal recessive OMIM AP4E1 573 NM_007347.4 99% Spastic paraplegia 51, autosomal recessive OMIM AP4M1 574 NM_004722.3 100% Spastic paraplegia 50, autosomal recessive OMIM AP4S1 575 NM_007077.4 100% Spastic paraplegia 52, autosomal recessive OMIM APTX 15984 NM_175073.2 100% Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) ARFGEF2 15853 NM_006420.2 99% Periventricular heterotopia with microcephaly OMIM ARG1 663 NM_000045.3 100% Argininemia OMIM ARHGAP31 29216 NM_020754.3 100% Adams-Oliver syndrome 1 OMIM ARHGEF6 685 NM_004840.2 100% Mental retardation, X-linked 46 OMIM ARHGEF9 14561 NM_015185.2 89% Epileptic encephalopathy, early infantile, 8 OMIM ARID1A 11110 NM_006015.4 95% Mental retardation, autosomal dominant 14 OMIM ARID1B 18040 NM_020732.3 93% Mental retardation, autosomal dominant 12 OMIM ARL6 13210 NM_177976.2 100% Bardet-Biedl syndrome 3 OMIM ARSA 713 NM_000487.5 100% Metachromatic leukodystrophy OMIM ARSE 719 NM_000047.2 100% Chondrodysplasia punctata, X-linked recessive OMIM ARX 18060 NM_139058.2 70% Hydranencephaly with abnormal genitalia OMIM Epileptic encephalopathy, early infantile, 1 OMIM Proud syndrome OMIM Partington syndrome OMIM Mental retardation, X-linked 29 and others OMIM Lissencephaly, X-linked 2 OMIM ASAH1 735 NM_177924.3 100% Spinal muscular atrophy with progressive myoclonic epilepsy OMIM Farber lipogranulomatosis OMIM ASL 746 NM_000048.3 100% Argininosuccinic aciduria OMIM ASPA 756 NM_000049.2 99% Canavan disease OMIM ASPM 19048 NM_018136.4 100% Microcephaly 5, primary, autosomal recessive OMIM ASS1 758 NM_000050.4 100% Citrullinemia OMIM ASXL1 18318 NM_015338.5 99% Bohring-Opitz syndrome OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) ATIC 794 NM_004044.6 99% AICA-ribosiduria due to ATIC deficiency OMIM ATM 795 NM_000051.3 97% Ataxia-telangiectasia OMIM ATP13A2 30213 NM_022089.3 99% ?Ceroid lipofuscinosis, neuronal, 12 OMIM Kufor-Rakeb syndrome OMIM ATP1A3 801 NM_152296.4 100% CAPOS syndrome OMIM Alternating hemiplegia of childhood 2 OMIM ATP6AP2 18305 NM_005765.2 99% ?Mental retardation, X-linked, syndromic, Hedera type OMIM ATP7A 869 NM_000052.6 98% Occipital horn syndrome OMIM Menkes disease OMIM ATR 882 NM_001184.3 99% Seckel syndrome 1 OMIM ATRX 886 NM_000489.4 99% Mental retardation-hypotonic facies syndrome, X-linked OMIM Alpha-thalassemia/mental retardation syndrome OMIM AUH 890 NM_001698.2 100% 3-methylglutaconic aciduria, type I OMIM AUTS2 14262 NM_015570.3 99% Mental retardation, autosomal dominant 26 OMIM B4GALT7 930 NM_007255.2 99% Ehlers-Danlos syndrome, progeroid type, 1 OMIM BBS1 966 NM_024649.4 100% Bardet-Biedl syndrome 1 OMIM BBS10 26291 NM_024685.3 100% Bardet-Biedl syndrome 10 OMIM BBS12 26648 NM_152618.2 98% Bardet-Biedl syndrome 12 OMIM BBS2 967 NM_031885.3 100% Bardet-Biedl syndrome 2 OMIM BBS4 969 NM_033028.4 100% Bardet-Biedl syndrome 4 OMIM BBS5 970 NM_152384.2 100% Bardet-Biedl syndrome 5 OMIM BBS7 18758 NM_176824.2 99% Bardet-Biedl syndrome 7 OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) BBS9 30000 NM_198428.2 100% Bardet-Biedl syndrome 9 OMIM BCAP31 16695 NM_001139441.1 100% Deafness, dystonia, and cerebral hypomyelination OMIM BCKDHA 986 NM_000709.3 100% Maple syrup urine disease, type Ia OMIM BCKDHB 987 NM_183050.2 100% Maple syrup urine disease, type Ib OMIM BCOR 20893 NM_017745.5 99% Microphthalmia, syndromic 2 OMIM BCS1L 1020 NM_004328.4 100% Bjornstad syndrome OMIM Mitochondrial complex III deficiency, nuclear type 1 OMIM Leigh syndrome OMIM BIN1 1052 NM_139343.2 99% Myopathy, centronuclear, autosomal recessive OMIM BLM 1058 NM_000057.3 99% Bloom syndrome OMIM BMP4 1071 NM_001202.3 100% Orofacial cleft 11 OMIM Microphthalmia, syndromic 6 OMIM BMPER 24154 NM_133468.4 99% Diaphanospondylodysostosis OMIM BOLA3 24415 NM_212552.2 100% Multiple mitochondrial dysfunctions syndrome 2 OMIM BRAF 1097 NM_004333.4 97% Cardiofaciocutaneous syndrome OMIM Noonan syndrome 7 OMIM LEOPARD syndrome 3 OMIM BRAT1 21701 NM_152743.3 95% Rigidity and multifocal seizure syndrome, lethal neonatal OMIM BRCA2 1101 NM_000059.3 100% Fanconi anemia, complementation group D1 OMIM BRIP1 20473 NM_032043.2 99% Fanconi anemia, complementation group J OMIM BRWD3 17342 NM_153252.4 99% Mental retardation, X-linked 93 OMIM BSND 16512 NM_057176.2 100% Bartter syndrome, type 4a OMIM Gen Gen (HGNC Transkript >10x Fenotype (symbol) ID) BTD 1122 NM_000060.3
Load more

Recommended publications
  • Description Treatment
    Description Megalencephaly, also called macrencephaly, is a condition in which an infant or child has an abnormally large, heavy, and usually malfunctioning brain. By definition, the brain weight is greater than average for the age and gender of the child. Head enlargement may be evident at birth or the head may become abnormally large in the early years of life. Megalencephaly is thought to be related to a disturbance in the regulation of cell production in the brain. In normal development, neuron proliferation - the process in which nerve cells divide to form new generations of cells - is regulated so that the correct number of cells is produced in the proper place at the appropriate time. In a megalencephalic brain, too many cells are produced either during development or progressively as part of another disorder, such as one of the neurofibromatoses or leukodystrophies. Symptoms of megalencephaly include delayed development, seizures, and corticospinal (brain cortex and spinal cord) dysfunction. Megalencephaly affects males more often than females. Unilateral megalencephaly or hemimegalencephaly is a rare condition that is characterized by the enlargement of one side of the brain. Children with this disorder may have a large, asymmetrical head accompanied by seizures, partial paralysis, and impaired cognitive development. Megalencephaly is different from macrocephaly (also called megacephaly or megalocephaly), which describes a big head, and which doesn’t necessarily indicate abnormality. Large head size is passed down through the generations in some families. Treatment There is no standard treatment for megalencephaly. Treatment will depend upon the disorder with which the megalencephaly is associated and will address individual symptoms and disabilities.
    [Show full text]
  • Megalencephaly and Macrocephaly
    277 Megalencephaly and Macrocephaly KellenD.Winden,MD,PhD1 Christopher J. Yuskaitis, MD, PhD1 Annapurna Poduri, MD, MPH2 1 Department of Neurology, Boston Children’s Hospital, Boston, Address for correspondence Annapurna Poduri, Epilepsy Genetics Massachusetts Program, Division of Epilepsy and Clinical Electrophysiology, 2 Epilepsy Genetics Program, Division of Epilepsy and Clinical Department of Neurology, Fegan 9, Boston Children’s Hospital, 300 Electrophysiology, Department of Neurology, Boston Children’s Longwood Avenue, Boston, MA 02115 Hospital, Boston, Massachusetts (e-mail: [email protected]). Semin Neurol 2015;35:277–287. Abstract Megalencephaly is a developmental disorder characterized by brain overgrowth secondary to increased size and/or numbers of neurons and glia. These disorders can be divided into metabolic and developmental categories based on their molecular etiologies. Metabolic megalencephalies are mostly caused by genetic defects in cellular metabolism, whereas developmental megalencephalies have recently been shown to be caused by alterations in signaling pathways that regulate neuronal replication, growth, and migration. These disorders often lead to epilepsy, developmental disabilities, and Keywords behavioral problems; specific disorders have associations with overgrowth or abnor- ► megalencephaly malities in other tissues. The molecular underpinnings of many of these disorders are ► hemimegalencephaly now understood, providing insight into how dysregulation of critical pathways leads to ►
    [Show full text]
  • Polymicrogyria (PMG) ‘Many–Small–Folds’
    Polymicrogyria Dr Andrew Fry Clinical Senior Lecturer in Medical Genetics Institute of Medical Genetics, Cardiff [email protected] Polymicrogyria (PMG) ‘Many–small–folds’ • PMG is heterogeneous – in aetiology and phenotype • A disorder of post-migrational cortical organisation. PMG often appears thick on MRI with blurring of the grey-white matter boundary Normal PMG On MRI PMG looks thick but the cortex is actually thin – with folded, fused gyri Courtesy of Dr Jeff Golden, Pen State Unv, Philadelphia PMG is often confused with pachygyria (lissencephaly) Thick cortex (10 – 20mm) Axial MRI 4 cortical layers Lissencephaly Polymicrogyria Cerebrum Classical lissencephaly is due Many small gyri – often to under-migration. fused together. Axial MRI image at 7T showing morphological aspects of PMG. Guerrini & Dobyns Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 2014 Jul; 13(7): 710–726. PMG - aetiology Pregnancy history • Intrauterine hypoxic/ischemic brain injury (e.g. death of twin) • Intrauterine infection (e.g. CMV, Zika virus) TORCH, CMV PCR, [+deafness & cerebral calcification] CT scan • Metabolic (e.g. Zellweger syndrome, glycine encephalopathy) VLCFA, metabolic Ix • Genetic: Family history Familial recurrence (XL, AD, AR) Chromosomal abnormalities (e.g. 1p36 del, 22q11.2 del) Syndromic (e.g. Aicardi syndrome, Kabuki syndrome) Examin - Monogenic (e.g. TUBB2B, TUBA1A, GPR56) Array ation CGH Gene test/Panel/WES/WGS A cohort of 121 PMG patients Aim: To explore the natural history of PMG and identify new genes. Recruited: • 99 unrelated patients • 22 patients from 10 families 87% White British, 53% male ~92% sporadic cases (NB. ascertainment bias) Sporadic PMG • Array CGH, single gene and gene panel testing - then a subset (n=57) had trio-WES.
    [Show full text]
  • CONGENITAL ABNORMALITIES of the CENTRAL NERVOUS SYSTEM Christopher Verity, Helen Firth, Charles Ffrench-Constant *I3
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.74.suppl_1.i3 on 1 March 2003. Downloaded from CONGENITAL ABNORMALITIES OF THE CENTRAL NERVOUS SYSTEM Christopher Verity, Helen Firth, Charles ffrench-Constant *i3 J Neurol Neurosurg Psychiatry 2003;74(Suppl I):i3–i8 dvances in genetics and molecular biology have led to a better understanding of the control of central nervous system (CNS) development. It is possible to classify CNS abnormalities Aaccording to the developmental stages at which they occur, as is shown below. The careful assessment of patients with these abnormalities is important in order to provide an accurate prog- nosis and genetic counselling. c NORMAL DEVELOPMENT OF THE CNS Before we review the various abnormalities that can affect the CNS, a brief overview of the normal development of the CNS is appropriate. c Induction—After development of the three cell layers of the early embryo (ectoderm, mesoderm, and endoderm), the underlying mesoderm (the “inducer”) sends signals to a region of the ecto- derm (the “induced tissue”), instructing it to develop into neural tissue. c Neural tube formation—The neural ectoderm folds to form a tube, which runs for most of the length of the embryo. c Regionalisation and specification—Specification of different regions and individual cells within the neural tube occurs in both the rostral/caudal and dorsal/ventral axis. The three basic regions of copyright. the CNS (forebrain, midbrain, and hindbrain) develop at the rostral end of the tube, with the spinal cord more caudally. Within the developing spinal cord specification of the different popu- lations of neural precursors (neural crest, sensory neurones, interneurones, glial cells, and motor neurones) is observed in progressively more ventral locations.
    [Show full text]
  • Classification of Congenital Abnormalities of the CNS
    315 Classification of Congenital Abnormalities of the CNS M. S. van der Knaap1 A classification of congenital cerebral, cerebellar, and spinal malformations is pre­ J . Valk2 sented with a view to its practical application in neuroradiology. The classification is based on the MR appearance of the morphologic abnormalities, arranged according to the embryologic time the derangement occurred. The normal embryology of the brain is briefly reviewed, and comments are made to explain the classification. MR images illustrating each subset of abnormalities are presented. During the last few years, MR imaging has proved to be a diagnostic tool of major importance in children with congenital malformations of the eNS [1]. The excellent gray fwhite-matter differentiation and multi planar imaging capabilities of MR allow a systematic analysis of the condition of the brain in infants and children. This is of interest for estimating prognosis and for genetic counseling. A classification is needed to serve as a guide to the great diversity of morphologic abnormalities and to make the acquired data useful. Such a system facilitates encoding, storage, and computer processing of data. We present a practical classification of congenital cerebral , cerebellar, and spinal malformations. Our classification is based on the morphologic abnormalities shown by MR and on the time at which the derangement of neural development occurred. A classification based on etiology is not as valuable because the various presumed causes rarely lead to a specific pattern of malformations. The abnor­ malities reflect the time the noxious agent interfered with neural development, rather than the nature of the noxious agent. The vulnerability of the various structures to adverse agents is greatest during the period of most active growth and development.
    [Show full text]
  • Unilateral Megalencephaly. Correlates
    523 Unilateral Megalencephaly: Correlation of MR Imaging and Pathologic Characteristics A. James Barkovich 1 Unilateral megalencephaly is a rare and poorly understood malformation resulting in Sylvester H. Chuang2 the enlargement of all or part of a cerebral hemisphere. The clinical and radiologic features of 12 patients with unilateral megalencephaly are presented; pathologic cor­ relation was available in four. All patients had seizures and developmental delay. Two were in congestive heart failure as a result of arteriovenous shunting through the abnormal hemisphere. The affected hemispheres showed a wide spectrum of involve­ ment. Anomalies of neuronal migration were present, and there was a roughly inverse correlation between the severity of hemispheric involvement and the magnitude of enlargement. This correlation is explained via a proposed mechanism of a mild hemi­ spheric insult in the middle-to-late second trimester. One patient had an extremely anomalous hemisphere that did not have characteristics of a neuronal migration anomaly and may have been a hamartomatous malformation. Our correlation of the clinical, radiologic, and pathologic features of unilateral mega­ lencephaly, together with a theory of pathogenesis, should help elucidate this rare malformation. AJNR 11:523-531, May{June 1990 Unilateral megalencephaly is a rare anomaly of the brain in which all or part of one hemisphere is enlarged in the absence of somatic hemihypertrophy [1- 8). We recently reviewed the imaging studies of 12 patients with this anomaly; histologic material was available in four of these. In this report, we describe the clinical , radiologic, and pathologic features of this anomaly and relate the pathologic anatomy to a proposed theory of pathogenesis.
    [Show full text]
  • Supratentorial Brain Malformations
    Supratentorial Brain Malformations Edward Yang, MD PhD Department of Radiology Boston Children’s Hospital 1 May 2015/ SPR 2015 Disclosures: Consultant, Corticometrics LLC Objectives 1) Review major steps in the morphogenesis of the supratentorial brain. 2) Categorize patterns of malformation that result from failure in these steps. 3) Discuss particular imaging features that assist in recognition of these malformations. 4) Reference some of the genetic bases for these malformations to be discussed in greater detail later in the session. Overview I. Schematic overview of brain development II. Abnormalities of hemispheric cleavage III. Commissural (Callosal) abnormalities IV. Migrational abnormalities - Gray matter heterotopia - Pachygyria/Lissencephaly - Focal cortical dysplasia - Transpial migration - Polymicrogyria V. Global abnormalities in size (proliferation) VI. Fetal Life and Myelination Considerations I. Schematic Overview of Brain Development Embryology Top Mid-sagittal Top Mid-sagittal Closed Neural Tube (4 weeks) Corpus Callosum Callosum Formation Genu ! Splenium Cerebral Hemisphere (11-20 weeks) Hemispheric Cleavage (4-6 weeks) Neuronal Migration Ventricular/Subventricular Zones Ventricle ! Cortex (8-24 weeks) Neuronal Precursor Generation (Proliferation) (6-16 weeks) Embryology From ten Donkelaar Clinical Neuroembryology 2010 4mo 6mo 8mo term II. Abnormalities of Hemispheric Cleavage Holoprosencephaly (HPE) Top Mid-sagittal Imaging features: Incomplete hemispheric separation + 1)1) No septum pellucidum in any HPEs Closed Neural
    [Show full text]
  • MR Imaging of N Euronal Migration Anomaly
    대 한 방 사 선 의 학 회 지 1991; 27(3) : 323~328 Journal of Korean Radiological Society. May. 1991 MR Imaging of N euronal Migration Anomaly Hyun Sook Hong, M.D., Eun Wan Choi, M.D., Dae Ho Kim, M.D., Moo Chan Chung, M.D., Kuy Hyang Kwon, M.D., Ki Jung Kim, M.D. Department o[ RadíoJogy. Col1ege o[ Medícine. Soonchunhyang University patients ranged in age from 5 months to 42 years with Introduction a mean of 16 years. The mean age was skewed by 2 patients with schizencephaly who were 35 and 42 Abnormalities of neuronal migration Sl re years old. characterized by anectopic location of neurons in the MR was performed with a 0:2T permanent type cerebral cortex (1-9). This broad group of anomalies (Hidachi PRP 20). Slice thickness was 5mm with a includes agyria. pachygyria. schizencephaly. 2.5mm interslice gap or 7.5mm thickness. Spin echo unilateral megalencephaly. and gray matter axial images were obtained. including Tl weighted hcterotopia. Patients with this anomaly present images (TIWI) with a repetition time (TR) of clinically with a variety of symptoms which are pro­ 400-500ms and echo time (TE) of 25-40ms. in­ portional to the extent of the brain involved. These termediate images of TR/TE 2000/38. and T2 abnormalities have been characterized pathologically weighted images (T2Wl) with a TR/TE of 2000/110. in vivo by sonography and CT scan (2. 3. 10-14. Occasionally. sagittal and coronal images were ob­ 15-21). tained. Gd-DTPA enhanced Tl WI were 려 so obtain­ MR appears to be an imaging technique of choice ed in 6 patients.
    [Show full text]
  • Brain Morphometric Analysis in Neurofibromatosis 1
    ORIGINAL CONTRIBUTION Brain Morphometric Analysis in Neurofibromatosis 1 Francis J. DiMario, Jr, MD; Gale R. Ramsby, MD; Joseph A. Burleson, PhD Rationale and Objectives: To investigate the rela- Results: Therewere27patients(20boys,aged1.0-17.7years; tionships between brain and skull base growth in pa- mean age, 8.8 years) and 43 controls (22 boys, aged 0.1-17.7 tients with neurofibromatosis 1 (NF1) compared with years; mean age, 5.9 years). The mean ages between groups healthy control subjects using brain magnetic reso- (boys, girls, and totals) were not statistically different. Sig- nance imaging (MRI) for morphometric analysis. nificant differences were appreciated for 6 of 24 measures. Patients with NF1 had a significantly larger bicaudate width Methods: Evaluated patients included children who (P = .002), biatrial width (P,.001), and biparietal diameter underwent T1- and T2-weighted or dual-echo proton (P = .003), but not hemispheric length. They also had sig- density axial and T1-weighted sagittal brain MRI from nificantly increased iter measures (P = .004), descending sig- January 1, 1988, to December 31, 1995. Study subjects moid sinus (P,.001), and an age-specific increase in brain- (n = 27) received a diagnosis of NF1 by accepted stem height (P = .03) not seen in controls. National Institutes of Health clinical criteria and were compared with an age- and sex-matched control group Conclusions: Patients with NF1 experience dynamic (n = 43). Twenty-four predetermined ventricular and changes in brain morphometry, resulting in a predomi- brain parenchymal dimensions and area calculations nant lateral volume expansion of the supratentorial com- were evaluated. Data were analyzed using 2-tailed t tests, partment and an increasing velocity of brainstem growth x2 analysis, analysis of variance, and analysis of covari- as they age.
    [Show full text]
  • The Identification and Validation of Neural Tube Defects in the General Practice Research Database
    THE IDENTIFICATION AND VALIDATION OF NEURAL TUBE DEFECTS IN THE GENERAL PRACTICE RESEARCH DATABASE Scott T. Devine A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Public Health (Epidemiology). Chapel Hill 2007 Approved by Advisor: Suzanne West Reader: Elizabeth Andrews Reader: Patricia Tennis Reader: John Thorp Reader: Andrew Olshan © 2007 Scott T Devine ALL RIGHTS RESERVED - ii- ABSTRACT Scott T. Devine The Identification And Validation Of Neural Tube Defects In The General Practice Research Database (Under the direction of Dr. Suzanne West) Background: Our objectives were to develop an algorithm for the identification of pregnancies in the General Practice Research Database (GPRD) that could be used to study birth outcomes and pregnancy and to determine if the GPRD could be used to identify cases of neural tube defects (NTDs). Methods: We constructed a pregnancy identification algorithm to identify pregnancies in 15 to 45 year old women between January 1, 1987 and September 14, 2004. The algorithm was evaluated for accuracy through a series of alternate analyses and reviews of electronic records. We then created electronic case definitions of anencephaly, encephalocele, meningocele and spina bifida and used them to identify potential NTD cases. We validated cases by querying general practitioners (GPs) via questionnaire. Results: We analyzed 98,922,326 records from 980,474 individuals and identified 255,400 women who had a total of 374,878 pregnancies. There were 271,613 full-term live births, 2,106 pre- or post-term births, 1,191 multi-fetus deliveries, 55,614 spontaneous abortions or miscarriages, 43,264 elective terminations, 7 stillbirths in combination with a live birth, and 1,083 stillbirths or fetal deaths.
    [Show full text]
  • Endosomal Trafficking Defects Alter Neural Progenitor Proliferation And
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.254037; this version posted August 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 2 Endosomal trafficking defects alter neural progenitor proliferation 3 and cause microcephaly 4 5 Jacopo A. Carpentieri1, Amandine Di Cicco1, David Andreau1, Laurence Del Maestro2, Fatima 6 El Marjou1, Laure Coquand1, Jean-Baptiste Brault1, Nadia Bahi-Buisson3, Alexandre D. 7 Baffet1,4,# 8 9 1- Institut Curie, PSL Research University, CNRS UMR144, 75005 Paris, France 10 2- Centre Épigénétique et destin cellulaire, Université Paris Diderot, CNRS UMR 7216, 75013 Paris, 11 France 12 3- INSERM U1163, Institut Imagine, Necker Hospital, 75015 Paris, France 13 4- Institut national de la santé et de la recherche médicale (Inserm) 14 # Corresponding author: [email protected] 15 16 Abstract 17 Primary microcephaly and megalencephaly are severe brain malformations defined by reduced 18 and increased brain size, respectively. Whether these two pathologies arise from related alterations at 19 the molecular level is unclear. Microcephaly has been largely associated with centrosomal defects, 20 leading to cell death. Here, we investigated the consequences of WDR81 loss of function, which cause 21 severe microcephaly in patients. We show that WDR81 regulates endosomal trafficking of EGFR, 22 and that loss of function leads to reduced MAP kinase pathway activation. Mouse radial glial 23 progenitor cells knocked-out for WDR81 display reduced proliferation rates, leading to reduced brain 24 size.
    [Show full text]
  • Chapter III: Case Definition
    NBDPN Guidelines for Conducting Birth Defects Surveillance rev. 06/04 Appendix 3.5 Case Inclusion Guidance for Potentially Zika-related Birth Defects Appendix 3.5 A3.5-1 Case Definition NBDPN Guidelines for Conducting Birth Defects Surveillance rev. 06/04 Appendix 3.5 Case Inclusion Guidance for Potentially Zika-related Birth Defects Contents Background ................................................................................................................................................. 1 Brain Abnormalities with and without Microcephaly ............................................................................. 2 Microcephaly ............................................................................................................................................................ 2 Intracranial Calcifications ......................................................................................................................................... 5 Cerebral / Cortical Atrophy ....................................................................................................................................... 7 Abnormal Cortical Gyral Patterns ............................................................................................................................. 9 Corpus Callosum Abnormalities ............................................................................................................................. 11 Cerebellar abnormalities ........................................................................................................................................
    [Show full text]